Corren, Jonathan
MD
Clinical Associate Professor of Medicine and Pediatrics Division of Clinical Immunology
and Allergy
Summary
Dr. Jonathan Corren was born and raised in the Los Angeles area. He graduated from the
University of California, Los Angeles, with honors in Biology and then completed his
medical training at the University of California, San Diego, School of Medicine.
Following his residency in Internal Medicine at the University of California, Davis, he
received fellowship training in Allergy and Clinical Immunology at the National Jewish
Medical and Research Center in Denver, Colorado. Dr. Corren accepted a faculty
position as staff physician and research associate at National Jewish until returning to Los
Angeles in 1991.
Dr. Corren is presently Associate Clinical Professor of Medicine at the University of
California, Los Angeles, where he is active in the training of medical students, residents,
and allergy fellows. He serves as Co-Director of the UCLA Nasal and Sinus Disease
Center and is Medical Director a the Allergy Research Foundation in Los Angeles,
California.
Contact address:
405 Hilgard Ave.
Los Angeles, CA. 90095
USA
Website: www.ucla.edu
Phone:
+1-310-825-4321
Fax:
+1-310-206-5976
Joncorren@hotmail.com
Research Interests: Clinical Immunology and Allergy
Employment History
 Clinical Associate Professor of Medicine and Pediatrics Division of Clinical
Immunology and Allergy
 Member, Clinical Faculty, UCLA
 Clinical Assistant Professor of Medicine2, UCLA


Medical Research Director, Allergy & Athma Specialists Ltd
Board Member, Allergy & Athma Specialists Ltd.
Source:
http://www.authoratory.com/authors/2007/1750035935/1/all.htm?&sid=0dc8f4910810b4
63aedd7005758ac6e3
http://www.healthgrades.com/directory_search/physician/profiles/dr-md-reports/DrJonathan-Corren-MD-1EC0DEAE.cfm
Publications:
1: Lee C, Corren J.
Review of azelastine nasal spray in the treatment of allergic and nonallergic rhinitis.
Expert Opin Pharmacother. 2007 Apr;8(5):701-9. Review.
PMID: 17376024
2: Corren J, Kachru R.
Relationship between nonallergic upper airway disease and asthma.
Clin Allergy Immunol. 2007;19:101-14. Review.
PMID: 17153010
3: Corren J.
The connection between allergic rhinitis and bronchial asthma.
Curr Opin Pulm Med. 2007 Jan;13(1):13-8. Review.
PMID: 17133119
4: Zeidler MR, Goldin JG, Kleerup EC, Kim HJ, Truong DA, Gjertson DW,
Kennedy NJ,
Newman KB, Tashkin DP, Silverman JM, Corren J.
Small airways response to naturalistic cat allergen exposure in
subjects with asthma.
J Allergy Clin Immunol. 2006 Nov;118(5):1075-81. Epub 2006 Sep 8.
PMID: 17088132
5: Corren J.
Evaluation and treatment of asthma: an overview.
Am J Manag Care. 2005 Nov;11(14 Suppl):S408-15; quiz S427-33.
PMID: 16300461
6: Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E.
Incidence and characteristics of angioedema associated with enalapril.
Arch Intern Med. 2005 Jul 25;165(14):1637-42.
PMID: 16043683
7: Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H;
Azelastine
Cetirizine Trial No. 1 (ACT 1) Study Group.
Effectiveness of azelastine nasal spray compared with oral cetirizine
in patients with seasonal allergic rhinitis.
Clin Ther. 2005 May;27(5):543-53.
PMID: 15978303
8: Corren J.
The rhinitis-asthma link revisited.
Ann Allergy Asthma Immunol. 2005 Mar;94(3):311-2. No abstract
available.
PMID: 15801240
9: Corren J, Fish H, Gumarange J.
Nasal response to natural cat allergen exposure is significantly
greater in patients with rhinitis and asthma than in patients with
rhinitis alone.
J Allergy Clin Immunol. 2005 Jan;115(1):202-3. No abstract available.
PMID: 15637570
10: Meltzer EO, Berman GD, Corren J, Pedinoff AJ, Doyle G, Waksman JA,
Butkerait P, Cooper SA, Berlin RG, Wason S.
Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the
treatment of seasonal allergic rhinitis.
Ann Allergy Asthma Immunol. 2004 Nov;93(5):452-9.
PMID: 15562884
11: Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK, Malice MP,
Massaad
R, Dass SB, Reiss TF, Wood RA.
Protective effect of montelukast on lower and upper respiratory tract
responses to short-term cat allergen exposure.
Ann Allergy Asthma Immunol. 2004 Nov;93(5):431-8.
PMID: 15562881
12: Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D,
Davancaze T, Adelman D.
Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on
nasal reactivity to allergen and local IgE synthesis.
Ann Allergy Asthma Immunol. 2004 Sep;93(3):243-8.
PMID: 15478383
13: LaForce CF, Corren J, Wheeler WJ, Berger WE; Rhinitis Study Group.
Efficacy of azelastine nasal spray in seasonal allergic rhinitis
patients who remain symptomatic after treatment with fexofenadine.
Ann Allergy Asthma Immunol. 2004 Aug;93(2):154-9.
PMID: 15328675
14: Zeidler M, Corren J.
Hydrofluoroalkane formulations of inhaled corticosteroids for the
treatment of
asthma.
Treat Respir Med. 2004;3(1):35-44. Review.
PMID: 15174892
15: Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL.
Rhinitis therapy and the prevention of hospital care for asthma: a
case-control study.
J Allergy Clin Immunol. 2004 Mar;113(3):415-9.
PMID: 15007339
16: Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor A, Gupta N.
Omalizumab is effective in the long-term control of severe allergic
asthma.
Ann Allergy Asthma Immunol. 2003 Aug;91(2):154-9.
PMID: 12952109
17: Corren J, Tashkin DP.
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for
the treatment of asthma.
Clin Ther. 2003 Mar;25(3):776-98. Review.
PMID: 12852702
18: Corren J, Casale T, Deniz Y, Ashby M.
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthmarelated emergency room visits and hospitalizations in patients with
allergic asthma.
J Allergy Clin Immunol. 2003 Jan;111(1):87-90.
PMID: 12532101
19: Schenkel E, Corren J, Murray JJ.
Efficacy of once-daily desloratadine/pseudoephedrine for relief of
nasal congestion.
Allergy Asthma Proc. 2002 Sep-Oct;23(5):325-30.
PMID: 12476542
20: Corren J, Casale T.
Immunomodulation of asthma: where do we stand?
Curr Allergy Asthma Rep. 2002 Nov;2(6):433-5. Review. No abstract
available.
PMID: 12359111